Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Surgical Information Systems (SIS) Earns Eleventh Consecutive #1 Client Rating in Ambulatory Surgical Center IT User Satisfaction, Black Book 2026 Survey
Healthcare & PharmaceuticalAwards

Surgical Information Systems (SIS) Earns Eleventh Consecutive #1 Client Rating in Ambulatory Surgical Center IT User Satisfaction, Black Book 2026 Survey

January 20, 2026 3:15 PM

Black Book Research today announced that Surgical Information Systems (SIS) has again been rated #1 overall in Ambulatory Surgical Center (ASC) health IT user satisfaction-marking its eleventh consecutive year as the top-rated vendor in this category, based on validated end-user survey feedback. Client experience results from 1,130 ASC IT users including physicians, clinicians, and administrative staff ranked SIS first among ASC-focused...

Read more
Prime Health GLP-1 Program Terms Guide 2026: Pricing, 10% Refund Policy Conditions, and the Fine Print Explained
Healthcare & PharmaceuticalAdvertorial

Prime Health GLP-1 Program Terms Guide 2026: Pricing, 10% Refund Policy Conditions, and the Fine Print Explained

January 20, 2026 1:20 PM

Disclosure: This sponsored advertorial is for informational purposes only and is not medical advice. A commission may be earned if you purchase through links in this article at no additional cost to you. Compounded medications are not FDA-approved finished products. Prime Health GLP-1 Program Terms Guide 2026: Compounded Semaglutide and Tirzepatide Pricing, 10% Refund Policy Requirements, and Key Disclosures Explained View the current Prime...

Read more
Beyond Benign’s Green Chemistry Commitment Earns 2025 RSC Horizon Prize for Education for Advancing Green Chemistry in Higher Education
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Beyond Benign’s Green Chemistry Commitment Earns 2025 RSC Horizon Prize for Education for Advancing Green Chemistry in Higher Education

January 20, 2026 11:00 AM

Beyond Benign's Green Chemistry Commitment (GCC) has been awarded the Royal Society of Chemistry's 2025 Horizon Prize for Education, recognizing its innovative approach to advancing green chemistry in higher education. The prize celebrates the GCC's success in fostering a global community of practice that empowers educators to embed green chemistry into teaching, research, and institutional culture-preparing future scientists with the skills...

Read more
Saint Therese of Oxbow Lake Earns 2025 Zellner Group Client of the Year Award
Healthcare & PharmaceuticalAwards

Saint Therese of Oxbow Lake Earns 2025 Zellner Group Client of the Year Award

January 20, 2026 10:10 AM

Senior living community Saint Therese of Oxbow Lake in Brooklyn Park has been named the 2025 Client of the Year by the Zellner Group, recognizing the community's outstanding partnership, leadership, and unwavering focus on resident-centered care. The Zellner Group is a senior health consulting firm that works with senior care organizations across Minnesota and western Wisconsin. The annual award honors one client organization that exemplifies...

Read more
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
Healthcare & PharmaceuticalCompany Update

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

January 20, 2026 9:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines to treat complex central nervous system disorders and improve the quality of life of patients, today announced the nationwide commercial launch of EXXUA and successful completion of its launch meeting last week that finalized sales training and launch preparations for EXXUA, the first and only selective 5-HT1A agonist...

Read more
Black Book Research Releases
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Releases "New Zealand Acute Care EMR & Digital Health 2026" Companion Report

January 20, 2026 9:00 AM

Black Book Research announced today the availability of its new report, "New Zealand Acute Care EMR & Digital Health 2026: Companion Research Report: Demand Drivers, National Platforms, Standards and Vendor Landscape." The report is now available as a complimentary download for stakeholders across New Zealand and the Australia-New Zealand (ANZ) digital health market:...

Read more
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
Healthcare & PharmaceuticalCompany Update

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

January 20, 2026 8:05 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced the Australian Patent Office has granted its patent application for its Spongilla technology combination as a method for treating acne. The patent, entitled "Compositions and methods for the treatment of skin conditions" (Australian Patent No. 2019419387), continues to strengthen Dermata's global...

Read more
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief
Healthcare & PharmaceuticalRegulatory

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief

January 20, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a new provisional patent application with the United States Patent and Trademark Office (USPTO). The application, titled "A Sublingual Powder Formulation of Alprazolam and Methods of Use Thereof," covers the first-ever sublingual powder formulation...

Read more
WellCheck Positions Its Health Equity Technology Platform as a Partner for Rural Health Systems Pursuing New Federal Funding
Healthcare & PharmaceuticalCompany Update

WellCheck Positions Its Health Equity Technology Platform as a Partner for Rural Health Systems Pursuing New Federal Funding

January 20, 2026 7:00 AM

As rural health systems across the United States prepare to pursue newly announced federal funding aimed at strengthening care delivery and access, WellCheck, a Baltimore-based health equity technology company, is reintroducing its platform as a trusted and proven solution designed to help rural communities connect services, close gaps in care, and demonstrate measurable impact. The Centers for Medicare & Medicaid Services (CMS) has committed...

Read more
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection
Healthcare & PharmaceuticalCompany Update

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

January 20, 2026 6:00 AM

Moderna, Inc. (NASDAQ:MRNA) and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced median five-year follow-up data from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy (INT), in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with high-risk melanoma (stage...

Read more
Shed GLP-1 Weight Loss Review 2026: Examining the Telehealth Platform's Process, Pricing, and Medication Options
Healthcare & PharmaceuticalAdvertorial

Shed GLP-1 Weight Loss Review 2026: Examining the Telehealth Platform's Process, Pricing, and Medication Options

January 20, 2026 1:20 AM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription treatments that require evaluation by a licensed healthcare provider. Always consult a qualified healthcare professional before starting any prescription treatment. If you purchase through affiliate links in this article, a commission may be earned at no additional cost to you. Shed Review 2026: A Closer Look at...

Read more
Measured Health Review 2026: GLP-1 Telehealth Weight Loss, Costs & Safety
Healthcare & PharmaceuticalAdvertorial

Measured Health Review 2026: GLP-1 Telehealth Weight Loss, Costs & Safety

January 19, 2026 5:15 PM

Disclaimer: This article is for informational purposes only and is not medical advice. Measured Health is a telehealth platform-it does not practice medicine. All prescribing decisions are made solely by licensed clinicians (through Measured-affiliated medical groups and/or Bridge, as applicable), and not all individuals will qualify for medication. Always consult a qualified healthcare professional before starting any prescription weight-loss...

Read more
Upstart Auto Refinancing Loans Review 2026: Rates, Savings & Who Qualifies
Healthcare & PharmaceuticalAdvertorial

Upstart Auto Refinancing Loans Review 2026: Rates, Savings & Who Qualifies

January 19, 2026 2:20 PM

Upstart This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented in this review. All opinions and descriptions are based on publicly available details and are intended to help readers make informed decisions. Upstart Auto Refinance Guide 2026: How the Platform Works,...

Read more
Ann Arbor Plastic Surgery Introduces Innovative Laser-Assisted Breast Augmentation for Enhanced Symmetry and Precision
Healthcare & PharmaceuticalProduct Announcements

Ann Arbor Plastic Surgery Introduces Innovative Laser-Assisted Breast Augmentation for Enhanced Symmetry and Precision

January 19, 2026 12:55 PM

Ann Arbor Plastic Surgery, a leading cosmetic surgery practice in Michigan, is proud to highlight its advanced laser-assisted breast augmentation designed to deliver greater precision and symmetry in breast enhancement procedures. With this cutting-edge technique, the practice strives to set new standards in aesthetic breast surgery by combining surgical artistry with thoughtful technological innovation. Led by board-certified surgeons Dr....

Read more
Desert Oasis Healthcare Supports Release of 7th Coachella Valley Community Health Survey, Advancing Data-Driven Community Impact
Healthcare & PharmaceuticalPartnerships

Desert Oasis Healthcare Supports Release of 7th Coachella Valley Community Health Survey, Advancing Data-Driven Community Impact

January 19, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) is proud to support Health Assessment and Research for Communities (HARC) as it releases the 7th Coachella Valley Community Health Survey during a special community event at UC Riverside-Palm Desert on February 26th. The Coachella Valley Community Health Survey Data Release Event will showcase the latest survey findings, providing valuable insights into the health, well-being, and lived experiences of people across...

Read more
Curiteva Receives FDA Nano Designation for Inspire 3D Printed Trabecular PEEK Technology
Healthcare & PharmaceuticalCompany Update

Curiteva Receives FDA Nano Designation for Inspire 3D Printed Trabecular PEEK Technology

January 19, 2026 8:00 AM

Curiteva, Inc., a leading privately held, technology-driven manufacturing company, announces the recent 510(k) clearance from the FDA for a nanotechnology designation for its Inspire 3D Printed Trabecular PEEK family of implants, featuring proprietary HAFUSE Surface Technology. This regulatory allowance highlights the implants' advanced physical and functional attributes, and advanced hydrophilicity, further strengthening the claims for the...

Read more
IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)
Healthcare & PharmaceuticalCompany Update

IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)

January 19, 2026 6:00 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that it has entered into a collaboration with the Danish biotech company Biomia to evaluate Biomia's drug candidates applying IRLAB's discovery platform, the Integrative Screening Process (ISP). "We are excited to enter into an ISP-based collaboration with Biomia, giving us the opportunity to leverage our...

Read more
BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF
Healthcare & PharmaceuticalCompany Update

BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF

January 19, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has completed and received preliminary results from its comparative pharmacokinetics ("PK") large-mass animal study in pigs. The study measured how efficiently cladribine is absorbed into the bloodstream over time and compared BioNxt's proprietary orally...

Read more
Genflow Biosciences PLC Announces Directorate Change
Healthcare & PharmaceuticalRegulatory

Genflow Biosciences PLC Announces Directorate Change

January 19, 2026 2:20 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a leading European-based biotechnology company focusing on gene therapies for age-related diseases, is pleased to announce a significant appointment to its Board of Directors, marking an important step in the Company's strategic evolution. Mr. Gad Berdugo, MSc Eng., MBA, has joined the Board with immediate effect and will assume the role of Independent Non-Executive...

Read more
PolyPeptide Successfully Closes Financial Year 2025 With Strong Revenue Growth and Marked Improvement in Profitability
Healthcare & PharmaceuticalEarnings

PolyPeptide Successfully Closes Financial Year 2025 With Strong Revenue Growth and Marked Improvement in Profitability

January 19, 2026 1:25 AM

PolyPeptide Group AG (SIX:PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful closing of its financial year 2025. Highlights PolyPeptide closes financial year 2025 with strong revenue growth and a marked improvement in profitability, in line with the revised guidance issued at the H1 2025 results Revenue of approximately EUR 389 million, representing an implied growth rate of circa...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?